Concepedia

Publication | Open Access

Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia

DOIFull Paper Access

235

Citations

29

References

2019

Year

Daniel A. Pollyea, Martin S. Tallman, Stéphane de Botton, Hagop M. Kantarjian, Robert H. Collins, Anthony S. Stein, Mark G. Frattini, Qiang Xu, Alessandra Tosolini, Wendy L. See,
Leukemia

References

YearCitations

Page 1